ASH 2023: PERSEUS Trial Overview

Rafael Fonseca, MD, discusses findings from the PERSEUS trial presented in December at ASH 2023.

Related Keywords

,Conference Perspectives ,Multiple Myeloma ,American Society Of Hematology ,Cash ,Newly Diagnosed Multiple Myeloma ,Triplet Therapy ,Quadruplet Therapy ,Perseus Trial ,Daratumumab ,Bortezomib ,Lenalidomide ,Dexamethasone ,Mvrd ,Transplant Eligible ,Fasct ,Master Trial ,Carfilzomib ,Nmrd ,Durable Response ,Four Drug Combination ,